BG27543A3 - Method of obtaining of n- aryl- n- (1- l- 4- piperidinyj)- arylacetamides - Google Patents

Method of obtaining of n- aryl- n- (1- l- 4- piperidinyj)- arylacetamides

Info

Publication number
BG27543A3
BG27543A3 BG7634265A BG3426576A BG27543A3 BG 27543 A3 BG27543 A3 BG 27543A3 BG 7634265 A BG7634265 A BG 7634265A BG 3426576 A BG3426576 A BG 3426576A BG 27543 A3 BG27543 A3 BG 27543A3
Authority
BG
Bulgaria
Prior art keywords
piperidinyj
arylacetamides
aryl
obtaining
Prior art date
Application number
BG7634265A
Other languages
Bulgarian (bg)
English (en)
Inventor
Sanczuk
Hermans
Original Assignee
Janssen Pharmaceutica N.V.,Be
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica N.V.,Be filed Critical Janssen Pharmaceutica N.V.,Be
Publication of BG27543A3 publication Critical patent/BG27543A3/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56Nitrogen atoms
    • C07D211/58Nitrogen atoms attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • C07D211/66Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having a hetero atom as the second substituent in position 4

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BG7634265A 1975-09-23 1976-09-23 Method of obtaining of n- aryl- n- (1- l- 4- piperidinyj)- arylacetamides BG27543A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61513175A 1975-09-23 1975-09-23
US71375676A 1976-08-12 1976-08-12

Publications (1)

Publication Number Publication Date
BG27543A3 true BG27543A3 (en) 1979-11-12

Family

ID=27087421

Family Applications (1)

Application Number Title Priority Date Filing Date
BG7634265A BG27543A3 (en) 1975-09-23 1976-09-23 Method of obtaining of n- aryl- n- (1- l- 4- piperidinyj)- arylacetamides

Country Status (29)

Country Link
JP (1) JPS6016417B2 (el)
AT (1) AT363935B (el)
AU (1) AU510029B2 (el)
BG (1) BG27543A3 (el)
CA (1) CA1068271A (el)
CH (1) CH628623A5 (el)
CS (1) CS222663B2 (el)
DE (1) DE2642856A1 (el)
DK (1) DK150478C (el)
ES (1) ES451768A1 (el)
FI (1) FI61482C (el)
FR (1) FR2325377A1 (el)
GB (1) GB1539473A (el)
GR (1) GR58469B (el)
HU (1) HU172964B (el)
IE (1) IE43802B1 (el)
IL (1) IL50522A (el)
IT (1) IT1073893B (el)
LU (1) LU75837A1 (el)
NL (1) NL187267C (el)
NO (1) NO147672C (el)
NZ (1) NZ181972A (el)
PH (1) PH12497A (el)
PL (2) PL192578A1 (el)
PT (1) PT65631B (el)
RO (1) RO70079A (el)
SE (1) SE427839B (el)
SU (1) SU747424A3 (el)
YU (1) YU39973B (el)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA765684B (en) * 1975-09-23 1978-04-26 Janssen Pharmaceutica Nv Novel n-aryl-n-(1-l-4-piperidinyl)-arylacetamides
JPS62260786A (ja) * 1986-05-08 1987-11-13 株式会社ヘキトク 燻瓦の製造ラインにおける焼成工程後の表面仕上げ装置
JO2769B1 (en) 2005-10-26 2014-03-15 جانسين فارماسوتيكا ان. في Rapid decomposition of physiologically antagonistic agents of the 2-dopamine receptor
JO2642B1 (en) 2006-12-08 2012-06-17 جانسين فارماسوتيكا ان. في Dopamine 2 receptor antagonists are rapidly hydrolyzed
JO2849B1 (en) 2007-02-13 2015-03-15 جانسين فارماسوتيكا ان. في Dopamine 2 receptor antagonists are rapidly hydrolyzed
JP2010525013A (ja) * 2007-04-23 2010-07-22 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 高速解離性ドパミン2受容体アンタゴニストとしてのピリジン誘導体
JP5431305B2 (ja) 2007-04-23 2014-03-05 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 高速解離性ドパミン2受容体アンタゴニストとしての4−アルコキシピリダジン誘導体
AU2008240729B2 (en) 2007-04-23 2012-08-23 Janssen Pharmaceutica N.V. Thia(dia)zoles as fast dissociating dopamine 2 receptor antagonists
CA2729313C (en) 2008-07-03 2016-08-30 Janssen Pharmaceutica Nv Substituted 6-(1-piperazinyl)-pyridazines as 5-ht6 receptor antagonists
DK2307374T3 (en) 2008-07-31 2017-05-01 Janssen Pharmaceutica Nv PIPERAZIN-1-YLTRIFLUORMETHYL-SUBSTITUTED PYRIDINES AS QUICK DISSOCATING DOPAMIN-2 RECEPTOR ANTAGONISTS

Also Published As

Publication number Publication date
CA1068271A (en) 1979-12-18
LU75837A1 (el) 1977-05-04
NO147672C (no) 1983-05-25
YU233676A (en) 1983-01-21
NO763054L (no) 1977-03-24
FI61482C (fi) 1982-08-10
DE2642856C2 (el) 1990-06-21
DK427876A (da) 1977-03-24
AU510029B2 (en) 1980-06-05
SE427839B (sv) 1983-05-09
SU747424A3 (ru) 1980-07-23
AU1787876A (en) 1978-03-23
YU39973B (en) 1985-06-30
FR2325377A1 (fr) 1977-04-22
DK150478B (da) 1987-03-09
NO147672B (no) 1983-02-14
JPS5239683A (en) 1977-03-28
RO70079A (ro) 1982-10-26
PT65631A (en) 1976-10-01
DE2642856A1 (de) 1977-03-24
IE43802B1 (en) 1981-06-03
PT65631B (en) 1978-07-05
SE7610501L (sv) 1977-03-24
NL7610513A (nl) 1977-03-25
AT363935B (de) 1981-09-10
NL187267B (nl) 1991-03-01
GB1539473A (en) 1979-01-31
DK150478C (da) 1987-10-05
CH628623A5 (en) 1982-03-15
ATA702976A (de) 1981-02-15
IE43802L (en) 1977-03-23
CS222663B2 (en) 1983-07-29
JPS6016417B2 (ja) 1985-04-25
PL192578A1 (pl) 1979-02-26
IT1073893B (it) 1985-04-17
FI762698A (el) 1977-03-24
IL50522A (en) 1979-09-30
IL50522A0 (en) 1976-11-30
GR58469B (en) 1977-10-14
PH12497A (en) 1979-04-05
PL117323B1 (en) 1981-07-31
ES451768A1 (es) 1978-05-01
NL187267C (nl) 1991-08-01
NZ181972A (en) 1978-07-28
FR2325377B1 (el) 1980-04-18
HU172964B (hu) 1979-01-28
FI61482B (fi) 1982-04-30

Similar Documents

Publication Publication Date Title
BG27553A3 (en) Method of obtaining of 2- phenyl- 3- aroylxenzothiophenes
BG27557A4 (en) Method of obtaining of cephemic compounds
BG24673A3 (en) Method of obtaining quinazone derivatives
BG27548A3 (en) Method of obtaining of carbonylsubstituated 1- sulphanylbenzimidazoles
BG27554A3 (en) Method of obtaining of derivatives of 2- aroyl- 3- phenyl- bewzothiophenes
BG27542A3 (en) Method of obtaining of 1- benzazolylalkyl- 4- substituated
JPS51136672A (en) Preparation method of 33methylpyridine
BG24799A3 (en) Method of obtaining benzoylureidediphenyl-esters
BG27355A3 (en) Method of obtaining of 11- desoxy- 16- ariloxy- w- tetranoprostaglandines
JPS5280987A (en) Method of forming can
BG31070A3 (en) Method for obtaining of 11- dexoxy- 16- aryl- w- tetranoprostagine
BG27899A3 (en) Method of obtaining of highdispersed cianurchloride
BG27543A3 (en) Method of obtaining of n- aryl- n- (1- l- 4- piperidinyj)- arylacetamides
BG24801A3 (en) Method of obtaining l-pyroglutamyl-l-prolineamide
JPS5280397A (en) Popymerization method of epsilonncaprolactam
BG27732A3 (en) Method of obtaining of di- substituated phenolethers of 3- amino- 2-hydroxipropane
BG32846A3 (en) Method for obtaining of n- methylcarbamide
BG28057A4 (en) Method of obtaining of 3- hydroxy- methylenchromanones
BG27555A3 (en) Method of obtaining of derivatives of aroyl- phenilnaphtalenes
JPS5250560A (en) Method of forming throughhhole
BG27373A3 (en) Method of obtaining of gamapyrones
JPS5224962A (en) Method of colddrolling
BG24228A3 (en) Method of preparing n-alkenyl-2-aminomethylpyrrolidine
JPS5219680A (en) Preparation method of chlorothianthrene
JPS51145588A (en) Method of continuous phtoopolymerization